CIK 0000025743 · Non-accelerated filer<br>Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870233535
- Phone
- 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-06 | Bernick Brian Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −3,167 | 10,517 | ||
| 2022-12-06 | Walker Marlan D General Counsel | Option exercise | +1,010 | 6,189 | ||
| 2022-12-06 | Walker Marlan D General Counsel | Option exercise | +1,156 | 7,345 | ||
| 2022-12-06 | Walker Marlan D General Counsel | Option exercise | +388 | 7,733 | ||
| 2022-12-06 | Walker Marlan D General Counsel | Sale | −1,048 | $4.95 | $5K | 6,685 |
| 2022-12-06 | Walker Marlan D General Counsel | Option exercise · Restricted Stock Unit | −1,010 | 1,010 | ||
| 2022-12-06 | Walker Marlan D General Counsel | Option exercise · Restricted Stock Unit | −1,156 | 2,311 | ||
| 2022-12-06 | Walker Marlan D General Counsel | Option exercise · Restricted Stock Unit | −388 | 770 | ||
| 2022-12-06 | Glickman Mark A Co-Chief Executive Officer | Option exercise | +1,734 | 1,734 | ||
| 2022-12-06 | Glickman Mark A Co-Chief Executive Officer | Sale | −440 | $4.92 | $2K | 1,294 |
| 2022-12-06 | Glickman Mark A Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −1,734 | 3,466 | ||
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Option exercise | +2,300 | 4,288 | ||
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Option exercise | +380 | 4,668 | ||
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Option exercise | +534 | 5,202 | ||
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Option exercise | +262 | 5,464 | ||
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Sale | −910 | $4.78 | $4K | 4,554 |
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Option exercise · Restricted Stock Units | −2,300 | 0 | ||
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Option exercise · Restricted Stock Units | −380 | 380 | ||
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Option exercise · Restricted Stock Units | −534 | 1,066 | ||
| 2022-12-06 | Donegan Michael C Interim CFO/CAO/VP of Finance | Option exercise · Restricted Stock Units | −262 | 519 |
Page 5 of 11 · 206 trades